Bio-Rad Laboratories Awarded for Product Line Strategy in the US RT-qPCR Market
News May 23, 2007
Frost & Sullivan selected Bio-Rad Laboratories, Inc.,as the recipient of the 2006 Frost & Sullivan Award for Product Line Strategy in the U.S. Reverse Transcription-Quantitative Polymerase Chain Reaction (RT-qPCR) market.
Bio Rad’s line of RT-qPCR instruments and reagents provides the research community with needed tools for complex genetic analysis.
From single target detection with the MyiQ™ Real-Time PCR System, to five-target detection with the iQ™5 Real-Time PCR System, Bio-Rad’s family of RT-qPCR instruments are available at different levels of sophistication for varying budgetary limits.
“Bio-Rad offers four different RT-qPCR instruments that meet the pricing and operational needs of researchers,” said Frost & Sullivan Research Analyst Shankar Sellappan, Ph.D. “All of the instruments have rapid ramp rates that minimize the time needed for cycles.”
Bio-Rad has relied upon its experience and knowledge of customer habits to tailor the instruments to maintain their ease of use. The basic platform of Bio-Rad’s PCR and RT-qPCR instruments is based on simplicity of design and the ability to individualize settings easily. This transparency in instrument operation has enabled more efficient use of tools and is expected to foster Bio-Rad’s market growth.
In addition to its RT-qPCR offerings, Bio-Rad caters to the entire field of molecular biology research with instruments and reagents that vary in complexity, from DNA/RNA gel electrophoresis, PCR and RT-PCR, and protein analysis, to software tools and other bioinformatics needed to analyze large amounts of data.
Each year Frost & Sullivan presents this Award to the company that demonstrated the most insight into customer needs and product demands. The recipient company has optimized its product line by leveraging products with the various price, performance, and feature points required by the market.
In recent years, numerous studies have shown that people who don't get enough sleep are at greater risk of stroke and heart attack. A study found that people who sleep fewer than 7 hours per night have lower blood levels of three physiological regulators, or microRNAs, which influence gene expression and play a key role in maintaining vascular health.